New Evidence-Based Guideline on HER2 Testing for Patients with Gastric Cancer 

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The College of American Pathologists, the American Society for Clinical Pathology, and the American Society of Clinical Oncology released an evidence-based clinical practice guideline on human epidermal growth factor receptor 2 testing for patients with gastroesophageal cancers.

To access this subscriber-only content please log in or renew your subscription.

Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.

Login Subscribe

YOU MAY BE INTERESTED IN

Colorectal cancer screening rates are similar among older adults despite varying 10-year mortality risks, UT Southwestern Medical Center researchers report in a study. The findings, published in The American Journal of Gastroenterology, challenge conventional age-based recommendations for CRC screening that don’t take into account factors like individual life expectancies and comorbidities.

Login